PROQR THERAPEUTICS EO-04 (0PQ) — Capital Reinvestment Ratio
Latest as of December 2023:
0.06x
PROQR THERAPEUTICS EO-04 (0PQ) has a Capital Reinvestment Ratio of 0.06x as of December 2023, meaning it reinvests 0% of its operating cash flow (€21.55 Million) in capital expenditures (€1.37 Million). See 0PQ free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
€21.55 Million
EUR
Capital Expenditures
€1.37 Million
EUR
Data as of
Dec 2023
Most recent filing
PROQR THERAPEUTICS EO-04 Capital Reinvestment Ratio (2023–2023)
This chart tracks PROQR THERAPEUTICS EO-04's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for PROQR THERAPEUTICS EO-04 (2023–2023)
Year-by-year Capital Reinvestment Ratio for PROQR THERAPEUTICS EO-04 from 2023 to 2023. For live market cap and broader valuation context, see 0PQ market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.06x | €21.55 Million | €1.37 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow